Ypsomed has been granted a patent for an autoinjector device designed to dispense liquid medication. The device features a housing, product container holder, needle protection sleeve, plunger rod, and dispensing spring. The innovative design ensures precise dosing and safe dispensing of medication. GlobalData’s report on Ypsomed gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Ypsomed, was a key innovation area identified from patents. Ypsomed's grant share as of May 2024 was 41%. Grant share is based on the ratio of number of grants to total number of patents.
Autoinjector device for dispensing liquid medication
A recently granted patent (Publication Number: US11992663B2) discloses an autoinjector device designed for dispensing liquid products, particularly medication. The autoinjector features a housing, a product container holder with a needle and piston, a needle protection sleeve, a plunger rod, and a prestressed dispensing spring. The device operates by displacing the plunger rod in a distal direction, causing the piston to dispense the product from the container. Additionally, the needle protection sleeve's movement triggers a locking mechanism that enables the engagement member to release, facilitating the product dispensing process.
Furthermore, the patent details a method for dispensing a liquid product using the autoinjector, involving positioning the needle protection sleeve on an insertion site and pressing the housing towards it. This action causes the needle protection sleeve to retract into the housing, exposing the needle tip for insertion. The method also includes features such as a needle protection spring, a sleeve-shaped mechanism holder, and a locking sleeve that work together to ensure safe and efficient product dispensing. Additionally, the method incorporates elements that generate acoustic or tactile signals to indicate the start of the dispensing process, enhancing user experience and safety during medication administration.
To know more about GlobalData’s detailed insights on Ypsomed, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
